There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Richard J. Forsyth is principal consultant with Forsyth Pharmaceutical Consulting, 907 Shamrock Ct, Royersford, PA 19468, tel. 484.535.1688, forsythpharmaconsulting@gmail.com.

Articles

Regulatory agencies expect companies to establish and monitor clean equipment- and dirty equipment-hold times for manufacturing equipment as part of their cleaning validation program.

Equipment Hold-Time for Cleaning Validation

Also, Alkermes announces restructuring and reduction of workforce, Icagen announces several senior management promotions, more...

Company and People Notes: Abbott and Takeda Agree to End TAP Venture; Kosan Biosciences Appoints Helen S. Kim as CEO; More

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The US Pharmacopeial Convention announced a revised glycerin monograph in the United States Pharmacopeia.

USP Issues Revised Glycerin Monograph

Also, Pipex Pharmaceuticals implements cost-cutting measures, Pfizer's Senior Vice-President and General Counsel Allen Waxman leaves the company, more...

Company and People Notes: AVI BioPharma Acquires Ercole Biotech, Cytomedix Appoints Martin P. Rosendale Executive Vice-President and COO, More

This year, INTERPHEX will take place in Philadelphia, Pennsylvania, on March 26?28. Equipment and Processing Report asked RJ Palermo, industry vice-president of Reed Life Sciences and INTERPHEX, to share his thoughts and expectations about the upcoming event.

Philadelphia Pharma: Pharmaceutical Technology Talks to INTERPHEX Head RJ Palermo

Concerns over contaminated heparin product worsened as US officials announced dialysis patients in Germany have fallen ill after using a different brand of the blood thinner than was already being recalled.

FDA 'Concerned' after Germany Reports More Heparin-Related Illnesses

Also, PDL BioPharma will no longer pursue sale of the company, executives resign from Topigen Pharmaceuticals, more...

Company and People Notes: Wyeth to Build Manufacturing Facility in China, Argolyn Bioscience Appoints M. Nixon Ellis President and CEO, More

The 59th Pittsburgh Conference gathered more than 1000 exhibitors on its showroom floor this week.

Pittcon 2008 Unveils Innovations in Analytics

Also, Millipore plans to open Singapore facility, Michael J. Simms joins Alexza Pharmaceuticals, more...

Company Notes: Crucell Makes Deal With Wyeth, Severin Schwan Becomes CEO of Roche Group, More

After two centuries, there's no reason to maintain two tablet compression tooling standards.